UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Immunopathology of inflammatory bowel disease

World journal of gastroenterology : WJG, 2014-01, Vol.20 (1), p.6-21

2014

Volltextzugriff (PDF)

Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice

BMC gastroenterology, 2012-05, Vol.12 (1), p.57-57, Article 57

2012

Volltextzugriff (PDF)

Immunopathogenesis of inflammatory bowel disease

World journal of gastroenterology : WJG, 2008-01, Vol.14 (3), p.390-400

2008

Volltextzugriff (PDF)

Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis

PloS one, 2011-01, Vol.6 (1), p.e16090-e16090

2011

Volltextzugriff (PDF)

Insights on the use of biosimilars in the treatment of inflammatory bowel disease

World journal of gastroenterology : WJG, 2017-03, Vol.23 (11), p.1932-1943

2017

Volltextzugriff (PDF)

High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures

PloS one, 2020-04, Vol.15 (4), p.e0231796-e0231796

2020

Volltextzugriff (PDF)

Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease

World journal of gastroenterology : WJG, 2011-10, Vol.17 (37), p.4166-4173

2011

Volltextzugriff (PDF)

Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis

Digestive diseases and sciences, 2019-07, Vol.64 (7), p.1844-1856

2019

Volltextzugriff (PDF)

Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome

Mucosal immunology, 2018-09, Vol.11 (5), p.1466-1476

2018

Volltextzugriff (PDF)

Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal Homeostasis

The Journal of immunology (1950), 2017-03, Vol.198 (5), p.2133-2146

2017

Volltextzugriff (PDF)

Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis

Mediators of inflammation, 2021-06, Vol.2021, p.5927064-21

2021

Volltextzugriff (PDF)

The protection role of Atg16l1 in CD11c+ dendritic cells in murine colitis

Immunobiology (1979), 2017-07, Vol.222 (7), p.831-841

2017

Volltextzugriff (PDF)

Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice

BMC gastroenterology, 2018-08, Vol.18 (1), p.127-127, Article 127

2018

Volltextzugriff (PDF)

TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization

Oxidative medicine and cellular longevity, 2021, Vol.2021 (1), p.3877617-3877617

2021

Volltextzugriff (PDF)

Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells

European journal of immunology, 2009-11, Vol.39 (11), p.3239-3250

2009

Volltextzugriff (PDF)

Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.3214-3223

2013

Volltextzugriff (PDF)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists

The American journal of medicine, 2018-09, Vol.131 (9), p.1017-1024

2018

Volltextzugriff (PDF)

Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis

Immunity (Cambridge, Mass.), 2018-12, Vol.49 (6), p.1077-1089.e5

2018

Volltextzugriff (PDF)

Sa1965 The Steady-State Pharmacokinetics of Adalimumab: Do We Need to Drink From the “Trough”?

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S418-S419

2016

Volltextzugriff (PDF)

Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD

United European Gastroenterology Journal, 2016-08, Vol.4 (4), p.531-540

2016

Volltextzugriff (PDF)

Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD

Inflammatory bowel diseases, 2015-02, Vol.21 (2), p.445-452

2015

Volltextzugriff (PDF)

Role of Foxa-2 in adipocyte metabolism and differentiation

The Journal of clinical investigation, 2003-08, Vol.112 (3), p.345-356

2003

Volltextzugriff (PDF)

Loss of HNF-1α Function in Mice Leads to Abnormal Expression of Genes Involved in Pancreatic Islet Development and Metabolism

Diabetes (New York, N.Y.), 2001-11, Vol.50 (11), p.2472-2480

2001

Volltextzugriff (PDF)

Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis

The Journal of experimental medicine, 2017-02, Vol.214 (2), p.401-422

2017

Volltextzugriff (PDF)

Mesenteric Adipose-derived Stromal Cells From Crohn’s Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis

Cellular and molecular gastroenterology and hepatology, 2018-01, Vol.6 (1), p.1-16

2018

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(224)

Publikationsform

Sprache

Englisch
(237)
Japanisch
(22)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunopathology of inflammatory bowel disease

Protective role of 1,25(OH)2vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice

Immunopathogenesis of inflammatory bowel disease

Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis

Insights on the use of biosimilars in the treatment of inflammatory bowel disease

High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures

Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease

Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis

Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome

Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal Homeostasis

Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis

The protection role of Atg16l1 in CD11c+ dendritic cells in murine colitis

Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice

TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization

Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells

Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists

Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis

Sa1965 The Steady-State Pharmacokinetics of Adalimumab: Do We Need to Drink From the “Trough”?

Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD

Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD

Role of Foxa-2 in adipocyte metabolism and differentiation

Loss of HNF-1α Function in Mice Leads to Abnormal Expression of Genes Involved in Pancreatic Islet Development and Metabolism

Defective ATG16L1-mediated removal of IRE1α drives Crohn's disease-like ileitis

Mesenteric Adipose-derived Stromal Cells From Crohn’s Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis

Suchergebnisse filtern